Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?


KÖSTEK O., HACıOĞLU M., Sakin A., DEMIR T., SARı M., OZKUL O., ...More

Cancer chemotherapy and pharmacology, vol.83, pp.115-122, 2019 (SCI-Expanded, Scopus) identifier identifier identifier